Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema: The <scp>OASIS</scp> study (a randomised control trial)-Reference-Cited by-同舟云学术

Intravitreal dexamethasone versus bevacizumab in Aboriginal and Torres Strait Islander patients with diabetic macular oedema: The OASIS study (a randomised control trial)

Published:2022-04-08 Issue:5 Volume:50 Page:522-533
ISSN:1442-6404
Container-title:Clinical & Experimental Ophthalmology
language:en
Short-container-title:Clinical Exper Ophthalmology

Author:

Meyer Joos¹²^ORCID,Fry Carly¹,Turner Angus¹²³,Razavi Hessom¹²³

Affiliation:

1. Lions Eye Institute Perth Western Australia Australia

2. Lions Outback Vision Lions Eye Institute Broome Werstern Australia Australia

3. Centre for Ophthalmology and Vision Sciences University of Western Australia Perth Western Australia Australia

Funder

Allergan Australia

Publisher

Wiley

Subject

Ophthalmology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ceo.14079

Reference27 articles.

1. The Prevalence and Causes of Vision Loss in Indigenous and Non-Indigenous Australians

2. Review of the prevalence of diabetic retinopathy in Indigenous Australians

3. Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between the response of intravitreal antivascular endothelial growth factor injection and systemic factors of diabetic macular edema;BMC Ophthalmology;2024-04-15

2. Comparing the efficacy of glucocorticoids and anti-VEGF in treating diabetic macular edema: systematic review and comprehensive analysis;Frontiers in Endocrinology;2024-03-22

3. Spotlighting retinal diseases;Clinical & Experimental Ophthalmology;2023-03-13